Company
Enara Bio
Shining a light on Dark Antigen® and T-cell biology to enable people to live free from the shadow of cancer
- Legal name
- Enara Bio Ltd.
Claim, correct or request removal
Record updated 23 September 2026
About
We are the leaders in discovering and validating Dark Antigens®, a rich source of novel cancer targets derived from areas of the genome previously considered to be ‘dark’ or non-coding. Through our proprietary EnTiCE® platform, we are developing first-in-class bispecific T-cell engagers against novel targets to improve treatment outcomes for broad populations of cancer patients.
Products
- Web
- ENA101
Loading relationship preview